Please login to the form below

Blog: Wearables – The Technologist’s view

Patient insight is key to a successful solution. The wearable technology market has come of age, with the emergence of wearables into the consumer mainstream. Products like Apple Watch and Fitbit have set the stage for an acceptance of products that are more focused around specific health outcomes.
The wearable technology market has come of age, with the emergence of wearables into the consumer mainstream. Products like Apple Watch and Fitbit have set the stage for an acceptance of products that are more focused around specific health outcomes.

Pharmaceutical companies seeking to support patients “beyond the pill” are excited by this opportunity. The wearables market is projected to be worth $25bn by 2019 – so adopting the most effective approach to product development will be critical for maximising returns. Companies must also consider the effect of the wearable technology on the patient and whether it might meet the definition of a regulated medical device.



blog_images_Wearables


If more than a decade’s experience in developing digital patient engagement for pharmaceutical companies has taught us anything, it’s that bringing patients into the development process is a fundamental part of a successful project.

Whatever the product, whether it’s a device for blood analysis or an app to promote healthy living, it’s important to engage with potential users as early as possible in the development process, to understand who they are, their environment, their routine, habits and drivers. These are foundational insights which technologists neglect at their peril.

Glynn Godwin, our VP Interactive & Design, shares his thoughts on the wearable technology market with Pharma Market Europe here  

This article was published by Ashfield Healthcare Communications, part of UDG Healthcare plc.





15th September 2016

Share

Tags

Company Details

Ashfield

Contact Website

Address:
Ashfield House
Resolution Road
Ashby de la Zouch
Leicestershire
LE65 1HW
UK

Latest content on this profile

Ashfield U.S. hires two senior executives for new Medical Affairs business unit
Ashfield U.S. is pleased to announce the appointment of Amy Van Sant as President of their new Medical Affairs business unit and Lee Ann Chaiken as Senior Vice President of Ashfield’s Pharmacovigilance business.
Ashfield
Infographic: The ingredients of a great Patient Service Team
Pharma wants to be customer-centred and the Patient Service Team model makes that a reality. A Patient Service Team sees doctors, nurses and pharmacists every day, focusing on how to help improve the lives of patients. They provide patient-focused messages and services.
Ashfield
Infographic: The four biggest vacancy management challenges and how to avoid them
Short-to-medium term vacancies in your organisation, whether temporary or permanent, are a huge challenge for the lean sales force. Recruiting and training the right candidate can be time consuming and costly, particularly when the vacancy is short term.
Ashfield
2018: A pivotal year for outsourcing
Managing Director of Ashfield Commercial and Clinical UK, Colin Watson, sat down with Pf Magazine to talk about meeting changing industry demands, new innovations for a new year and why people power is so vital to future success…
Ashfield
Infographic: Sales outsourcing as a change partner
Ashfield explored the future of outsourcing with 16 senior sales professionals from European pharmaceutical companies. We’ve summarised the key insights in our infographic, ‘Sales outsourcing as a change partner in the pharmaceutical sector.’
Ashfield
See why so many clients choose the Ashfield contact centre in our new video
Contact centres are an increasingly popular way for pharmaceutical and healthcare companies to target customers in a more holistic way than field medical sales reps alone.
Ashfield